Insider Trading & Ownership of Prathyusha Duraibabu

Location
Richmond, CA
Summary
The estimated net worth of Prathyusha Duraibabu is at least $996,436 dollars as of 20 Feb 2026. Prathyusha Duraibabu is the Director of Organogenesis Holdings Inc. and owns shares of Organogenesis Holdings Inc. (ORGO) stock worth about $733.4K. Prathyusha Duraibabu is the PRINCIPAL FINANCIAL OFFICER of SANGAMO THERAPEUTICS, INC and owns shares of SANGAMO THERAPEUTICS, INC (SGMO) stock worth about $263K.
Signature
/s/ William R. Kolb, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Prathyusha Duraibabu and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Prathyusha Duraibabu has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $996,436.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Organogenesis Holdings Inc. ($733,410).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Prathyusha Duraibabu

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ORGO Organogenesis Holdings Inc. Director $733,410 18 Feb 2026
SGMO SANGAMO THERAPEUTICS, INC Principal Financial Officer $263,026 22 Jan 2026

Insider Transactions Reported by Prathyusha Duraibabu:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .